BLNK
BLNK (B cell linker, also known as SLP65, SLP-65, BASH, Ly57 and bca) is a cytoplasmic adaptor protein that links B-cell receptor-associated kinase activation to downstream signalling. It plays a critical role in B-cell development and function. Browse Assay Genie's current range of BLNK research reagents below, or read on for the biology behind the target.
BLNK functions as a central linker protein downstream of the B-cell receptor (BCR). It bridges the kinase SYK to a multitude of signalling pathways and so shapes the biological outcome of B-cell function and development. It contributes to the activation of ERK/EPHB2, MAP kinase p38 and JNK, modulates AP1 activation, and is important for activation of NF-kappa-B and NFAT. It also plays an important role in BCR-mediated PLCG1 and PLCG2 activation and Ca(2+) mobilisation, and is required for trafficking of the BCR to late endosomes.
Its role is selective. BLNK does not appear to be required for pre-BCR-mediated activation of MAP kinase and phosphatidylinositol 3 (PI3) kinase signalling. It may be required for the RAC1-JNK pathway and may contribute to BCR-induced B-cell apoptosis. Phosphorylation of five tyrosine residues is necessary for BLNK to nucleate distinct signalling effectors after BCR activation. Most importantly, it plays a critical role in orchestrating the pro-B cell to pre-B cell transition.
The BLNK gene belongs to the SH2 domain containing group and encodes a cytoplasmic protein that is also found at the cell membrane. Alternatively spliced transcript variants have been reported. Mutations in the gene cause hypoglobulinaemia with absent B cells, a disease in which the pro- to pre-B-cell transition is developmentally blocked. Deficiency of the protein has also been observed in some cases of pre-B acute lymphoblastic leukaemia. Mouse and rat orthologs are both named Blnk.
BLNK bridges SYK to downstream pathways, including PLCG1, PLCG2 and Ca(2+) mobilisation, making it a key node for studying BCR signal transduction.
BLNK orchestrates the pro-B to pre-B cell transition, so it is central to work on early B-lymphocyte differentiation.
BLNK is important for NF-kappa-B and NFAT activation and modulates AP1, linking receptor engagement to gene regulation.
BLNK mutations cause hypoglobulinaemia with absent B cells, and deficiency occurs in some pre-B acute lymphoblastic leukaemia cases.
BLNK is a linker protein downstream of the B-cell receptor. It bridges SYK to multiple signalling pathways, supports PLCG1 and PLCG2 activation and Ca(2+) mobilisation, and helps drive the pro-B to pre-B cell transition during B-cell development.
BLNK, or B cell linker, is also called SLP65, SLP-65, BASH, Ly57 and bca. UniProt names the protein B-cell linker protein. Alternatively spliced transcript variants exist, and one is listed under the alias BLNK-s.
Yes. Mutations in the BLNK gene cause hypoglobulinaemia and absent B cells, with a developmental block at the pro- to pre-B-cell transition. Deficiency has also been seen in some pre-B acute lymphoblastic leukaemia. Mouse and rat orthologs are both called Blnk; check the datasheet of any product for its validated reactivity.
Other B-cell receptor signalling proteins, SH2 domain adaptors and downstream pathway partners with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q8WV28; product specifications from Assay Genie datasheets.